Neogen Corporation
NEOGHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeNeogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. At a $1.95B market cap, Neogen Corporation ranks as a small-cap company within healthcare. It operates through two segments, Food Safety and Animal Safety.
Market Cap
$1.95B
Beta
1.84
P/E (TTM)
—
P/E (Fwd)
30.24
EPS (TTM)
$-2.80
EPS (Fwd)
$0.30
ROE
-25.6%
ROA
-0.6%
Cash
$159.9M
Total Debt
$795.1M
Free CF
$19.5M
52W Change
57.6%
Annual Financials
Cash vs Debt
The company holds $159.9M in cash, though total debt stands at $795.1M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $19.5M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at -25.6%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $527.2M (2022) to $894.7M (2025), reflecting a 70% increase over the period.
With a beta above 1.5, NEOG tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. No single metric tells the full story. Reviewing NEOG's risk profile alongside its fundamentals and technical indicators provides a more complete picture.